Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Ventus Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel small-molecule drugs for previously undruggable or poorly treated targets. Their pipeline includes…

Ventus Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel small-molecule drugs for previously undruggable or poorly treated targets. Their pipeline includes…
Stage: Clinical-stage biopharma
Founded: 2020
Lead programs: VENT-02 (NLRP3, PD), VENT-03 (cGAS, lupus)
Platform: ReSOLVE® (AI/ML, structural biology, protein science, biophysics)
Employees: 97
Reported total funding: ≈ $370.15M
Innate immunity, inflammation, neurology, and oncology-relevant targets addressed with small molecules.
2020
Biopharmaceuticals
$60,000,000
Participation from GV
$100,000,000
$140,000,000
Major participation from RA Capital Management and other life-science investors
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week